Indivior Announces FY and Q4 2024 Financial Results

Core Insights - Indivior PLC announced its financial results for the period ending December 31, 2024, highlighting its ongoing commitment to treating substance use disorders [1] - The company is focused on transforming substance use disorders from a global crisis to a recognized chronic disease, aiming to provide evidence-based treatment to patients worldwide [3] Company Overview - Indivior is a global pharmaceutical company headquartered in Richmond, VA, employing over 1,000 individuals and offering products in over 30 countries [3] - The company specializes in developing medicines for substance use disorders, particularly focusing on opioid use disorder treatments [3] Financial Presentation - A live webcast presentation regarding the financial results will be hosted by CEO Mark Crossley, scheduled for 13:00 BST (8:00 am ET) [2] - The earnings release and investor presentation will be accessible on the company's website [4]